Advisornet Financial’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
Other funds holding IBRX
Advisornet Financial's IBRX Position: Q2 2026 in Review
Advisornet Financial held its ImmunityBio (IBRX) position steady in Q2 2026 at 2,143 shares worth $18.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1407.
Advisornet Financial first reported a position in IBRX in Q1 2021 and has held it in 22 quarters since. 404 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.
- Advisornet Financial held 2,143 shares of ImmunityBio worth $18.8K as of Q2 2026.
- Advisornet Financial left its ImmunityBio share count unchanged in Q2 2026.
- ImmunityBio made up ﹤0.01% of Advisornet Financial's portfolio in Q2 2026, its #1407 holding.
- Advisornet Financial first reported a position in ImmunityBio in Q1 2021 and has held it in 22 quarters since.
- 404 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.
Based on Advisornet Financial's 13F filing for Q2 2026, filed 23 Jul 2026.